A method can include milling a plurality of silicon particles to form a plurality of milled silicon particles. The milled silicon particles can optionally include collecting the milled silicon particles, powdering the milled silicon particles, and milling the milled silicon particles a second time.

The present application is related to cancer immunotherapy, e.g. stimulation of T cell mediated anti-tumor therapy. Accordingly, described herein are methods of inducing or enhancing an adaptive immune response to a cancer in a subject and methods of treating cancer in a subject. In some embodiments, the methods hyperactivate dendritic cells (DCs), which induce T helper type I (TH1) and cytotoxic T lymphocyte (CTL) responses in the absence of TH2 immunity.

Methods of forming cement pastes, methods of forming concrete, and methods of forming other compositions using mineral particles formed from the one or more of biomineralizing microorganisms and biomineralizing microorganisms. Desired features, such as size and morphology, can be controlled by controlling growth parameters of the biomineralizing microorganisms and biomineralizing microorganisms.

A cristobalite includes: a d50 particle size selected within a range of from 1 μm to 15 μm; an L color coordinate of greater than 96; a color coordinate of less than 1; and a b color coordinate of 1 or less, in which the cristobalite is a powder. Also provided are compositions containing the cristobalite, coatings formed with compositions, and methods of preparing cristobalite.

A silicon material can include a silicon aggregate comprising a plurality of porous silicon nanoparticles welded together. The silicon aggregate can optionally have a polyhedral morphology. A method can include: receiving a plurality of porous silicon nanoparticles and cold welding the plurality of porous silicon nanoparticles into an aggregated silicon particle.

A method may include wet ball milling a plurality of iron nitride nanoparticles in the presence of a surface active agent to modify a surface of the plurality of iron nitride nanoparticles and form a plurality of surface-modified iron nitride nanoparticles for a variety of biomedical applications and soft magnetic materials related applications.

The present invention provides an alumina particle containing molybdenum (Mo) and an inorganic coating part provided on the surface of the alumina particle.

The present invention relates to a composite and a manufacturing method thereof, wherein the composite includes a base powder, an adhesive disposed on the surface of the base powder, and functional particles disposed on the adhesive, wherein the adhesive includes at least one of a fatty primary monoamide and a fatty secondary monoamide.

A filler for resinous composition is contained and used in resinous composition, and includes: a crystalline siliceous particulate material with a crystal structure made of at least one member selected from the group consisting of type FAU, type FER, type LTA and type MFI, and/or type MWW; and a surface treatment agent including an organic silica compound reacted with or adhered to a surface of the crystalline siliceous particulate material; the filler including the surface treatment agent in an amount falling in a range allowing the filler to exhibit a negative thermal expansion coefficient.

A silicon material can include a silicon aggregate comprising a plurality of porous silicon nanoparticles welded together. The silicon aggregate can optionally have a polyhedral morphology. A method can include: receiving a plurality of porous silicon nanoparticles and cold welding the plurality of porous silicon nanoparticles into an aggregated silicon particle.